Skip to main content

Advertisement

SpringerLink
Log in

Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Existing evidence suggests that pro-inflammatory cytokines increases during chemotherapy which plays an intermediary role in Chemotherapy related cognitive impairment (CRCI) and thyroid dysregulation. Previous studies suggest that thyroid hormones are essential for neuronal development and neurotransmitter release. CHOP regimen has been the backbone of Non-Hodgkin’s lymphoma (NHL) treatment from a decade but rituximab addition to CHOP (R-CHOP) has improved cure rates. However, their adverse event profile on behavior is not well studied on patients. In this study total 68 NHL patients were enrolled and divided equally in 2 groups as CHOP receiving (n = 34) and R-CHOP receiving (n = 34). Effects of R-CHOP and CHOP regimen on thyroid function, pro-inflammatory cytokines and cognitive function were determined at four time points that was from one day before 1st (TP0), 2nd (TP1), 3rd (TP2) and 4th (TP3) cycle of chemotherapy. Results indicated significant increase in levels of pro-inflammatory cytokines after each time point from TP0 to TP3of chemotherapy. Thyroid hormone levels i.e. T3, T4 were found significantly decreased and TSH was increased after each time point of both groups. MMSE score was found significantly decreased after each cycle of both groups. However, an inverse association was found between IL-1β levels with TSH by applying correlation coefficient. Cognitive function was decreased in patients with decreased T3 and T4 levels and increased TSH. To conclude, patients receiving R-CHOP regimen were found to have more increased IL-6 and IL-1β with more cognitive decline and thyroid abnormality as comparison to CHOP receiving patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anthony DC, Bolton SJ, Fearn S, Perry VH (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain : a journal of neurology 120(Pt 3):435–444

    Article  Google Scholar 

  • Ashizawa K, Yamashita S, Tobinaga T, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S (1989) Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol 121:465–469

    CAS  PubMed  Google Scholar 

  • Aurer I, Eghbali H, Raemaekers J, Khaled HM, Fortpied C, Baila L, van der Maazen RW (2011) Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin’s lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). Eur J Haematol 86:111–116

    Article  CAS  PubMed  Google Scholar 

  • Bannwarth B, Schaeverbeke T, Pehourcq F, Vernhes JP, D’Yvoire MB, Dehais J (1997) Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data Revue du rhumatisme (English ed) 64:301–304

    CAS  Google Scholar 

  • Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E (1998) Role of cytokines in the pathogenesis of the euthyroid sick syndrome. European journal of endocrinology / European Federation of Endocrine Societies 138:603–614

    Article  CAS  Google Scholar 

  • Baudino B, D’Agata F, Caroppo P, Castellano G, Cauda S, Manfredi M, Geda E, Castelli L, Mortara P, Orsi L, Cauda F, Sacco K, Ardito RB, Pinessi L, Geminiani G, Torta R, Bisi G (2012) The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the So 56:559–568

    CAS  Google Scholar 

  • Beex L, Ross A, Smals A, Kloppenborg P (1977) 5-fluorouracil-induced increase of total serum thyroxine and triiodothyronine. Cancer treatment reports 61:1291–1295

    CAS  PubMed  Google Scholar 

  • Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of cancer survivorship : research and practice 3:223–232

    Article  Google Scholar 

  • Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, et al. (1991) Medical history and the risk of Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group International journal of epidemiology 20(Suppl 2):S36–S42

    PubMed  Google Scholar 

  • Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 23:2547–2552

    Article  CAS  Google Scholar 

  • Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, Lee JA, Fan G, Tan YP, Yong WS, Madhukumar P, Loo SK, Ang SF, Wong M, Chay WY, Ooi WS, Dent RA, Yap YS, Ng R, Chan A (2015) Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studydagger. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 26:1446–1451

    Article  CAS  Google Scholar 

  • Chung YC, Chang YF (2003) Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83:222–226

    Article  PubMed  Google Scholar 

  • Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919–2925

    Article  PubMed  Google Scholar 

  • Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer’s disease. Romanian journal of internal medicine =. Revue roumaine de medecine interne 49:55–58

    CAS  PubMed  Google Scholar 

  • Davies PH, Black EG, Sheppard MC, Franklyn JA (1996) Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol 44:199–205

    Article  CAS  Google Scholar 

  • de Groot S, Janssen LG, Charehbili A, Dijkgraaf EM, Smit VT, Kessels LW, van Bochove A, van Laarhoven HW, Meershoek-Klein Kranenbarg E, van Leeuwen-Stok AE, van de Velde CJ, Putter H, Nortier JW, van der Hoeven JJ, Pijl H, Kroep JR (2015) Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Res Treat 149:461–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, Sacco RL, Elkind MS (2013) Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study. Neuroepidemiology 40:253–259

    Article  PubMed  PubMed Central  Google Scholar 

  • Forlenza OV, Diniz BS, Talib LL, Mendonca VA, Ojopi EB, Gattaz WF, Teixeira AL (2009) Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 28:507–512

    Article  CAS  PubMed  Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–98

  • Galantino ML, Lew J, Williams S, Farrar J, Sowers K, Quinn J, Stricker CT, Cotrell S, Russo L, Brown DC (2008) Change in Perception of Cognitive Function and Quality of Life Over Time in Women Receiving Adjuvant Chemotherapy for Breast Cancer. J Cognit Rehabil 4–13

  • Gani DK, Mallineni SK, Ambalavanan R, Deepalakshmi EP (2012) Estimation of the levels of C-reactive protein, interleukin-6, total leukocyte count, and differential count in peripheral blood smear of patients with chronic periodontitis in a south Indian population. The West Indian medical journal 61:826–831

    CAS  PubMed  Google Scholar 

  • Garnick MB, Larsen PR (1979) Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy. N Engl J Med 301:252–253

    Article  CAS  PubMed  Google Scholar 

  • Hefti F, Hartikka J, Bolger MB (1986) Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cells. Brain Res 375:413–416

    Article  CAS  PubMed  Google Scholar 

  • Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M (1983) Alzheimer’s disease: genetic aspects and associated clinical disorders. Ann Neurol 14:507–515

    Article  CAS  PubMed  Google Scholar 

  • Hogervorst E, Huppert F, Matthews FE, Brayne C (2008) Thyroid function and cognitive decline in the MRC cognitive function and ageing study. Psychoneuroendocrinology 33:1013–1022

    Article  CAS  PubMed  Google Scholar 

  • Huang J, Jin L, Ji G, Xing L, Xu C, Xiong X, Li H, Wu K, Ren G, Kong L (2013) Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine. BMC Cancer 13:334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hull M, Fiebich BL, Lieb K, Strauss S, Berger SS, Volk B, Bauer J (1996) Interleukin-6-associated inflammatory processes in Alzheimer’s disease: new therapeutic options. Neurobiol Aging 17:795–800

    Article  CAS  PubMed  Google Scholar 

  • Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 38:926–934

    Article  PubMed  Google Scholar 

  • Jacob PS, Nath S, Patel RP (2014) Evaluation of interleukin-1beta and 8 in gutka chewers with periodontitis among a rural Indian population. Journal of periodontal & implant science 44:126–133

    Article  CAS  Google Scholar 

  • Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP, Morrow GR (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20:831–839

    Article  Google Scholar 

  • Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32:1151–1163

    Article  PubMed  Google Scholar 

  • Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, LeFel J, Schagen SB, Ahles TA, Wefel JS, Vardy JL, Pancre V, Lange M, Castel H (2015) Impact of cancer and its treatments on cognitive function: advances in research from the Paris international cognition and cancer task force symposium and update since 2012. J Pain Symptom Manag 50:830–841

    Article  Google Scholar 

  • Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17(Suppl 1):S112–S118

    Article  CAS  PubMed  Google Scholar 

  • Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, Dhabhar FS (2013) Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun 30(Suppl):S109–S116

    Article  CAS  PubMed  Google Scholar 

  • Khan MA, Bhurani D, Agarwal NB (2015) Alteration of thyroid function in Indian HER 2-negative breast cancer patients undergoing chemotherapy. Asian Pacific journal of cancer prevention : APJCP 16:7701–7705

    Article  PubMed  Google Scholar 

  • Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, Hill R, Smith K, Gross H, Morrow GR (2007) Self-reported cognitive impairment in patients with cancer. Journal of oncology practice / American Society of Clinical Oncology 3:54–59

    Article  Google Scholar 

  • Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A (2004) Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472:113–129

    Article  PubMed  Google Scholar 

  • Kulkarni HS, Kasi PM (2012) Rituximab and cytokine release syndrome. Case Reports in Oncology 5:134–141

    Article  PubMed  PubMed Central  Google Scholar 

  • Massart C, Le Tellier C, Lucas C, Gibassier J, Leclech G, Nicol M (1992) Effects of cisplatin on human thyrocytes in monolayer or follicle culture. J Mol Endocrinol 8:243–248

    Article  CAS  PubMed  Google Scholar 

  • Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108–118

    Article  PubMed  Google Scholar 

  • Munir F, Burrows J, Yarker J, Kalawsky K, Bains M (2010) Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs 19:1362–1370

    Article  PubMed  Google Scholar 

  • Nolte A, Bechtner G, Rafferzeder M, Gartner R (1994) Interleukin-1 beta (IL-1 beta) binds to intact porcine thyroid follicles, decreases iodide uptake but has no effect on cAMP formation or proliferation. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 26:413–418

    Article  CAS  PubMed  Google Scholar 

  • Plosker GL, Figgitt DP (2003) Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs 63:803–843

    Article  CAS  PubMed  Google Scholar 

  • Ramos-Remus C, Gonzalez-Castaneda RE, Gonzalez-Perez O, Luquin S, Garcia-Estrada J (2002) Prednisone induces cognitive dysfunction, neuronal degeneration, and reactive gliosis in rats. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 50:458–464

    Article  CAS  Google Scholar 

  • Reid-Arndt SA, Hsieh C, Perry MC (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psycho-Oncology 19:535–544

    Article  PubMed  PubMed Central  Google Scholar 

  • Scherling CS, Smith A (2013) Opening up the window into "chemobrain": a neuroimaging review. Sensors (Basel, Switzerland) 13:3169–3203

    Article  CAS  Google Scholar 

  • Seigers R, Fardell JE (2011) Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 35:729–741

    Article  PubMed  Google Scholar 

  • Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European journal of oncology nursing : the official journal of European Oncology Nursing Society 11:6–15

    Article  Google Scholar 

  • Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, Kivimaki M (2014) Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 83:486–493

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Smith JW, Evans AT, Costall B, Smythe JW (2002) Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 26:45–60

    Article  CAS  PubMed  Google Scholar 

  • Stuart NS, Woodroffe CM, Grundy R, Cullen MH (1990) Long-term toxicity of chemotherapy for testicular cancer--the cost of cure. Br J Cancer 61:479–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sutherland MK, Wong L, Somerville MJ, Handley P, Yoong L, Bergeron C, McLachlan DR (1992) Reduction of thyroid hormone receptor c-ERB a alpha mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain. Neurobiol Aging 13:301–312

    Article  CAS  PubMed  Google Scholar 

  • Tannock IF, Ahles TA, Ganz PA, Van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22:2233–2239

    Article  Google Scholar 

  • Tominaga T, Yamashita S, Nagayama Y, Morita S, Yokoyama N, Izumi M, Nagataki S (1991) Interleukin 6 inhibits human thyroid peroxidase gene expression. Acta Endocrinol 124:290–294

    CAS  PubMed  Google Scholar 

  • Torino F, Barnabei A, Appetecchia M, Baldelli R (2012) Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. INTECH Open Access Publisher

  • Torino F, Barnabei A, Paragliola R, Baldelli R, Appetecchia M, Corsello SM (2013) Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid : official journal of the American Thyroid Association 23:1345–1366

    Article  CAS  Google Scholar 

  • Torres SM, McKeever PJ, Johnston SD (1991) Effect of oral administration of prednisolone on thyroid function in dogs. Am J Vet Res 52:416–421

    CAS  PubMed  Google Scholar 

  • van der Kolk LE, Grillo-Lopez AJ, Baars JW, Hack CE, van Oers MH (2001) Complement activation plays a key role in the side-effects of rituximab treatment. Br J Haematol 115:807–811

    Article  PubMed  Google Scholar 

  • Vardy J, Tannock I (2007) Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 63:183–202

    Article  PubMed  Google Scholar 

  • Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 19:623–629

    Article  CAS  Google Scholar 

  • Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549–1563

    Article  CAS  PubMed  Google Scholar 

  • Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer LJ (2002) Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58:1055–1061

    Article  CAS  PubMed  Google Scholar 

  • Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology 12:703–708

    Article  PubMed  Google Scholar 

  • Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041–2056

    Article  PubMed  Google Scholar 

  • Wood LJ, Nail LM, Gilster A, Winters KA, Elsea CR (2006) Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 33:535–542

    Article  PubMed  Google Scholar 

  • Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P’Eng FK, Chi CW (1996) Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91:1417–1422

    CAS  PubMed  Google Scholar 

  • Wu Y, Jia Y, Xu J, Shuai X, Wu Y (2013) Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-alpha antagonist and cytokine profiling: a case-report and review of the literature. J Clin Pharm Ther 38:249–253

    Article  CAS  PubMed  Google Scholar 

  • Yeung SC, Chiu AC, Vassilopoulou-Sellin R, Gagel RF (1998) The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev 19:144–172

    Article  CAS  PubMed  Google Scholar 

  • Zimmer P, Mierau A, Bloch W, Struder HK, Hulsdunker T, Schenk A, Fiebig L, Baumann FT, Hahn M, Reinart N, Hallek M, Elter T (2015) Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leukemia & lymphoma 56:347–352

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Translational & Clinical Research, Faculty of Science, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, 110062, India

    Mohd Ashif Khan & Nidhi Bharal Agarwal

  2. Department of Pharmaceutical Medicine, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India

    Mohd Ashif Khan

  3. Department of Pharmacology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, 110029, India

    Kamlesh Garg

  4. Chief of Haemato-Oncology Services & Senior Bone Marrow Transplant Specialist, Rajiv Gandhi Cancer Institute & Research Centre, Rohini, New Delhi, 110085, India

    Dinesh Bhurani

Authors
  1. Mohd Ashif Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamlesh Garg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dinesh Bhurani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nidhi Bharal Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nidhi Bharal Agarwal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, M.A., Garg, K., Bhurani, D. et al. Early manifestation of mild cognitive impairment in B-cell non-Hodgkin’s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy. Naunyn-Schmiedeberg's Arch Pharmacol 389, 1253–1265 (2016). https://doi.org/10.1007/s00210-016-1290-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-016-1290-y

Keywords

Search

Navigation